Last updated: 11/17/2021 12:00:10
Efficacy of manual toothbrushes in removing dental plaque
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Completed
Completed
Trial overview
Official title: Randomized Controlled Examiner-Blind Methodology Development Study To Investigate The Plaque Removal Efficacy Of Manual Toothbrushes In Healthy Dentate Subjects
Trial description: This clinical methodology development study will evaluate the plaque removal efficacy of four marketed manual toothbrushes, with differing bristle types and brush head designs, in healthy dentate participants. Changes in supra-gingival plaque accumulation will be assessed after first use and following 1-and 4-weeks treatment (twice-daily brushing), using two different clinical measures of dental plaque. Study participants will abstain from oral hygiene for a period of 12-18 hours prior to each assessment visit. Data generated will inform the design of future clinical studies investigating the plaque removal efficacy of manual toothbrushes.
Primary purpose:
Other
Trial design:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Allocation:
Randomized
Primary outcomes:
Change from pre-brushing to post-brushing in mean Rustogi Modified Navy Plaque Index (RPI) overall (all sites assessed) after a single brushing event (first use)
Timeframe: Day 0
Change from pre- to post-brushing in mean Turesky Modified Quigley & amp Hein Plaque Index (TPI) overall (all sites assessed) after a single brushing event (first use)
Timeframe: Day 0
Secondary outcomes:
Change from baseline (Day 0 pre-brushing assessment) to Day 7 post-brushing assessment and to Day 28 post-brushing assessment in mean RPI after single use - overall (all sites assessed)
Timeframe: Day 0, Day 7, day 28
Change from baseline (Day 0 pre-brushing assessment) to Day 7 post-brushing assessment and to Day 28 post-brushing assessment in mean TPI after single use - overall (all sites assessed)
Timeframe: Day 0, Day 7, Day 28
Mean RPI (overall, all sites assessed) pre- and post-brushing values at Day 7 and day 28
Timeframe: Day 7, Day 28
Mean TPI (overall, all sites assessed) pre- and post-brushing values at Day 7 and day 28
Timeframe: Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 0 post-brushing, to Day 7 post-brushing and to Day 28 post-brushing assessment in mean RPI after single use (gingival margin sites)
Timeframe: Day 0, Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 0 post-brushing, to Day 7 post-brushing and to Day 28 post-brushing assessment in mean RPI after single use (inter-proximal sites)
Timeframe: Day 0, Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 0 post-brushing, to Day 7 post-brushing and to Day 28 post-brushing assessment in mean TPI after single use (inter-proximal sites)
Timeframe: Day 0, Day 7, Day 28
Mean RPI (gingival margin sites) pre-and post-brushing values at Day 0, Day 7 and Day 28
Timeframe: Day 0, Day 7, Day 28
Mean RPI (interproximal sites) pre-and post-brushing values at Day 0, Day 7 and Day 28
Timeframe: Day 0, Day 7, Day 28
Mean TPI (interproximal sites) pre-and post-brushing values at Day 0, Day 7 and Day 28
Timeframe: Day 0, Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 7 pre-brushing and to Day 28 pre-brushing assessment in mean RPI overall (all sites assessed)
Timeframe: Day 0, Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 7 pre-brushing and to Day 28 pre-brushing assessment in mean TPI overall (all sites assessed)
Timeframe: Day 0, Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 7 pre-brushing and to Day 28 pre-brushing in mean RPI gingival margin sites
Timeframe: Day 0, Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 7 pre-brushing and to Day 28 pre-brushing in mean RPI interproximal sites
Timeframe: Day 0, Day 7, Day 28
Change from baseline (Day 0 pre-brushing) to Day 7 pre-brushing and to Day 28 pre-brushing in mean TPI interproximal sites
Timeframe: Day 0, Day 7, Day 28
Interventions:
Other: Oral B Indicator 123
Other: Dr Best Original
Other: Dr Best Multi Expert
Other: parodontax Interdental
Enrollment:
80
Observational study model:
Not applicable
Primary completion date:
2019-10-12
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
Dental Plaque, Oral Hygiene
Product
sodium fluoride
Collaborators
Not applicable
Study date(s)
September 2019 to December 2019
Type
Interventional
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
18 - 65 Years
Accepts healthy volunteers
Yes
- An individual must meet all the following inclusion criteria to be eligible for enrollment into the study.
- Participant provision of a signed and dated informed consent document indicating that the participant has been informed of all pertinent aspects of the study before any assessment is performed.
- An individual who meets any of the following exclusion criteria will not be eligible for enrollment into the study.
- A participant who is an employee of the investigational site, either directly involved in the conduct of the study or otherwise supervised by the investigator, or a member of their immediate family; or a GSK CH employee directly involved in the conduct of the study or a member of their immediate family.
Inclusion and exclusion criteria
Inclusion criteria:
- An individual must meet all the following inclusion criteria to be eligible for enrollment into the study.
- Participant provision of a signed and dated informed consent document indicating that the participant has been informed of all pertinent aspects of the study before any assessment is performed.
- A participant who is willing and able to comply with scheduled visits, treatment plan and other study procedures.
- A participant in good general, mental and oral health with, in the opinion of the investigator or medically qualified designee, no clinically significant or relevant abnormalities in medical history or upon oral examination, or condition, that would impact the participant’s safety, well-being or the outcome of the study, if they were to participate in the study, or affect the individual’s ability to understand and follow study procedures and requirements.
- A participant with, in the opinion of the investigator or medically qualified designee, satisfactory oral hygiene based on oral examination.
- A participant who routinely uses a manual toothbrush for daily oral hygiene.
- VISIT 1 (Screening): A participant must have a) ≥ 20 natural, permanent teeth b) ≥ 40 gradable tooth surfaces (≥ 2/3rds of the tooth surface assessable for RPI).Third molars, fully crowned/ extensively restored, grossly carious, orthodontically-banded/bonded or abutment teeth and surfaces with calculus deposits which, in the opinion of the clinical examiner, would interfere with plaque assessment should not be included in the gradable surface count. Third molars can be included if, as a result tooth loss, they are functioning as second molars.
- VISIT 2 (Baseline): A participant must have a pre-brushing mean RPI ≥ 0.6 overall (that is, the mean over all gradable surfaces)
Exclusion criteria:
- An individual who meets any of the following exclusion criteria will not be eligible for enrollment into the study.
- A participant who is an employee of the investigational site, either directly involved in the conduct of the study or otherwise supervised by the investigator, or a member of their immediate family; or a GSK CH employee directly involved in the conduct of the study or a member of their immediate family.
- A participant who has participated in other studies (including non-medicinal studies) involving investigational product(s) in the 30 days prior to study entry and/or who is participating in other studies during study participation.
- A participant with, in the opinion of the investigator or medically qualified designee, an acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator or medically qualified designee, would make the participant inappropriate for entry into this study.
- A participant with any medical/oral condition which, in the opinion of the investigator or medically qualified designee, could impact study outcomes (for example, oral dryness).
- A participant taking daily doses of medication/having daily treatments which, in the opinion of the investigator or medically qualified designee, could impact study outcomes (for example, is causing oral dryness).
- A participant with any condition or physical limitation which, in the opinion of the investigator or medically qualified designee, impacts their ability to perform oral hygiene with a manual toothbrush.
- A participant who is pregnant (self-reported; no pregnancy test required) or intending to become pregnant over the course of the study.
- A participant who is breastfeeding.
- A participant with known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
- A participant who is unwilling or unable to comply with the following Lifestyle Considerations described in this protocol: 1) Dental Product/Treatment and Oral Hygiene Restrictions i)From Screening (Visit 1) to the Participant’s Last Study Visit: a) Participants should not use any other oral care products (for example, toothpastes, toothbrushes, oral rinses, tongue cleaners, whitening/bleaching products, inter-dental cleaning products)than those provided during the study. Note: dental floss (non-antibacterial) can be used to remove impacted food; b) Participants should not chew gum or consume any confectionery containing xylitol (e.g. sugar-free mints); c) Participants should delay any non-emergency dental treatment until after study completion (including dental prophylaxis); d)Participants should delay any tooth whitening treatments (professional and/or home use) until after study completion; ii) Before Clinical Efficacy Assessment Visits (Visits 2-4): Participants should refrain from oral hygiene procedures for 12-18 hours before their visit; 2) Meals and Dietary Restrictions i) Before Clinical Efficacy Assessment Visits (Visits 2-4): Participants should not eat or drink for ≥ 1 hour before their visit and until all visit procedures have been completed.
- A participant who has had routine dental prophylaxis within 4 weeks of Screening.
- A participant who has undergone a tooth bleaching procedure within 8 weeks of Screening.
- A participant with, in the opinion of the investigator or medically qualified designee, generalized moderate/severe gingivitis.
- A participant with, in the opinion of the investigator or medically qualified designee, gross periodontal disease.
- A participant with, in the opinion of the investigator or medically qualified designee, signs of active periodontitis.
- A participant with a Basic Periodontal Examination (BPE) score ≥ 3 in any sextant.
- A participant who has undergone treatment for periodontal disease within 12 months of Screening, including scaling and/or root surface debridement.
- A participant who is currently undergoing treatment for periodontal disease, including scaling and/or root surface debridement.
- A participant with active caries which, in the opinion of the investigator or medically qualified designee, could impact study outcomes or the oral health of the participant if they were to participate in the study.
- A participant with, in the opinion of the investigator or medically qualified designee, evidence of gross intra-oral neglect or the need for extensive dental therapy.
- A participant with restorations in a poor state of repair which, in the opinion of the investigator or medically qualified designee, could impact study outcomes.
- A participant with any dental condition (e.g. malalignment, overcrowding) which, in the opinion of the investigator or medically qualified designee, could impact study outcomes.
- A participant with high levels of extrinsic dental stain or calculus deposits which, in the opinion of the investigator or medically qualified designee, would interfere with plaque assessment or impact study outcomes.
- A participant with a tongue or lip piercing.
- A participant with multiple dental implants which, in the opinion of the investigator or medically qualified designee, could impact study outcomes.
- A participant with fixed bridge(s) or removable partial dentures.
- A participant with fixed or removable orthodontic braces/bands or a fixed orthodontic retainer.
- A participant who has had fixed or removable orthodontic braces/bands within 3 months of Screening.
- A participant who is unwilling to forgo use of an orthodontic retainer for the duration of the study, provided there would be no impact on the outcome of any previous, completed orthodontic treatment or the participant’s well-being.
- VISIT 1 (Screening): A participant who has taken antibiotics within 2 weeks of Screening.
- VISIT 2 (Baseline): A participant who has taken antibiotics during the lead-in period (between Screening and Visit 2).
- Participant with a recent history (within the last year) of alcohol or other substance abuse.
- A participant who, in the opinion of the investigator or medically qualified designee, should not participate in the study.
- A participant who has previously been enrolled in this study.
Trial location(s)
Location
GSK Investigational Site
Birmingham, West Midlands, United Kingdom, B5 7EG
Status
Study Complete
Study documents
Clinical study report
Available language(s): English
Protocol
Available language(s): English
Statistical analysis plan
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Results posted on ClinicalTrials.gov
Recruitment status
Completed
Actual primary completion date
2019-10-12
Actual study completion date
2019-10-12
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website